Providence Health & Services
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1859-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.providence.org
Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients
- First Posted Date
- 2017-09-20
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 9
- Registration Number
- NCT03289364
- Locations
- 🇺🇸
Providence Cancer Center, Portland, Oregon, United States
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-08-14
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 22
- Registration Number
- NCT03247712
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab
- Conditions
- First Posted Date
- 2017-05-17
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 34
- Registration Number
- NCT03157830
- Locations
- 🇺🇸
RWJBarnabas Health, Livingston, New Jersey, United States
🇺🇸Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, Washington, United States
🇺🇸Kadlec Neuroscience Center, Richland, Washington, United States
Caring for the Whole Person
- Conditions
- Interventions
- Other: Access to CareOther: Depression ScreeningOther: Patient-Provider RelationshipOther: Patient-Clinic InteractionsOther: StigmaOther: Provider ContinuityOther: Symptom SeverityOther: DiagnosesOther: Social supportOther: Preventive ScreeningOther: Inpatient Hospitalization UtilizationOther: Inpatient ReadmissionsOther: Post-Admission follow-up
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2017-06-15
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 6000
- Registration Number
- NCT03034369
- Locations
- 🇺🇸
Center for Outcomes Research and Education, Providence Health & Services, Portland, Oregon, United States
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
- Conditions
- Interventions
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 16
- Registration Number
- NCT02950259
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Pathogen Detection and Community Acquired Pneumonia
- Conditions
- Interventions
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 570
- Registration Number
- NCT02880384
- Locations
- 🇺🇸
Portland Providence Medical Center, Portland, Oregon, United States
Ipilimumab for Head and Neck Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2016-06-24
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 18
- Registration Number
- NCT02812524
- Locations
- 🇺🇸
Portland Providence Medical Center, Portland, Oregon, United States
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 29
- Registration Number
- NCT02734290
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Providence Cancer Center, Portland, Oregon, United States
Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 100
- Registration Number
- NCT02688725
- Locations
- 🇺🇸
Providence Regional Cancer Partnership, Everett, Washington, United States
ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2024-01-25
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 50
- Registration Number
- NCT02688712
- Locations
- 🇺🇸
Providence Cancer Center, Portland, Oregon, United States